EBS · Emergent Biosolutions Inc
United States · RS rating 21 · As of 2026-11-03
| Price | 6.25 USD |
|---|---|
| 1-day change | -3.0% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 29 / 35 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 23 / 8 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -214.3% |
| Sales growth Q/Q | -35.2% |
| Distance from 52-week high | +55.0% |
| Market cap (USD) | $417.8M |